Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Leerink Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$70M
Portfolio companies 16
Rounds per year 0.59
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Exits 12
Key employees 1

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Genetics
  • Therapeutics
Summary

Leerink Partners is the famous Corporate Investor, which was founded in 1995. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Boston.

The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TESARO, AlloVir, Living Proof. We can highlight the next thriving fund investment areas, such as Medical, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The overall number of key employees were 1.

The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Leerink Partners, startups are often financed by Atlas Venture, Omega Funds, The Column Group. The meaningful sponsors for the fund in investment in the same round are Foresite Capital, Fidelity Management and Research Company, Cormorant Asset Management. In the next rounds fund is usually obtained by The Baupost Group, Omega Funds, North Bridge Venture Partners & Growth Equity.

Considering the real fund results, this Corporate Investor is 13 percentage points less often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2018. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Leerink Partners performs on 31 percentage points more the average number of lead investments. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Leerink Partners:
Typical Co-investors
Leerink Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Leerink Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avanade Seattle, United States, Washington
B3Forin -
Brava Investments New York, New York, United States
Caretech Pte Inc Central, Central Region, Singapore
Crocker Mountain Capital -
Epic Games Cary, North Carolina, United States
Furman Selz Inc New York, New York, United States
Heartland Payment Systems New Jersey, Princeton, United States
Innov8on Mazowieckie, Poland, Warsaw
Khaleeji Commercial Bank Bahrain, Capital Governorate, Manama
Loomis AB Stockholm, Stockholm County, Sweden
New Vantage Group Mclean, United States, Virginia
Raga Partners New York, New York, United States
RFW Banro Investments -
Senmed Medical Ventures -
Shaka Ventures Kenya, Nairobi, Nairobi Area
ShareLink Capital China, Shanghai
Skayle Central, Central Region, Singapore
Weiji Investment China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Odyssey Therapeutics

Biotechnology
Health Care
$101M05 Dec 2023 Cambridge, Massachusetts, United States

Kinnate Biopharma

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$98M26 Aug 2020 San Diego, California, United States

AlloVir

Biotechnology
Clinical Trials
Pharmaceutical
$120M23 May 2019 Houston, Texas, United States

Fulcrum Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$80M05 Sep 2018 Cambridge, Massachusetts, United States

Precision BioSciences

Biotechnology
Genetics
Health Care
Medical
$110M08 Jun 2018 Durham, North Carolina, United States

Fog Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$66M16 May 2018 Cambridge, Massachusetts, United States

Generation Bio

Biotechnology
Genetics
Health Care
$100M27 Feb 2018 Cambridge, Massachusetts, United States

Avrobio

Biotechnology
Genetics
Health Care
$60M01 Feb 2018 Cambridge, Massachusetts, United States

Arcus Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$107M13 Nov 2017 Hayward, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Leerink Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 17
Average round size 70M
Rounds per year 0.59
Peak activity year 2018
Lead investments 1
Follow on index 0.06
Exits 12
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Odyssey Therapeutics

Biotechnology
Health Care
$101M05 Dec 2023 Cambridge, Massachusetts, United States

Kinnate Biopharma

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$98M26 Aug 2020 San Diego, California, United States

AlloVir

Biotechnology
Clinical Trials
Pharmaceutical
$120M23 May 2019 Houston, Texas, United States

Fulcrum Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$80M05 Sep 2018 Cambridge, Massachusetts, United States

Precision BioSciences

Biotechnology
Genetics
Health Care
Medical
$110M08 Jun 2018 Durham, North Carolina, United States

Fog Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$66M16 May 2018 Cambridge, Massachusetts, United States

Generation Bio

Biotechnology
Genetics
Health Care
$100M27 Feb 2018 Cambridge, Massachusetts, United States

Avrobio

Biotechnology
Genetics
Health Care
$60M01 Feb 2018 Cambridge, Massachusetts, United States

Arcus Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$107M13 Nov 2017 Hayward, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: